The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

Trump announced reciprocal tariffs that could take effect against US trading partners, including India, as soon as April. The ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Indian pharma exporters must unite and report challenges in exports to overcome trade barriers: Raja Bhanu: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The ...

India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...